Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantitative Parameters of Diffusion Spectrum Imaging: Correlation With Histopathologic Characteristics in Patients With Breast Cancer

NCT05159323 is registered in ClinicalTrials.gov with Xiang Zhang as lead sponsor.

NCT NCT05159323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05159323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantitative Parameters of Diffusion Spectrum Imaging: Correlation With Histopathologic Characteristics in Patients With Breast Cancer
Lead sponsor
Xiang Zhang
Phase
Not applicable
Overall status
Unknown status
Start date
August 20, 2021
Completion date
August 19, 2022
Enrollment
64 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma; magnetic resonance imaging; diffusion spectrum imaging